Description: The instructions for acetylcysteine capsules were issued by the State Pharmaceutical Products Supervision and Administration in July 2002, with the number 12 "Notice on Publishing the Catalogue of Instructions for the Sixth Batch of Chemicals". The instructions published by the State Administration of Pharmaceutical Products are reference samples for revising the specifications. In case of doubt, the enterprise may propose amendments. Indications should be consistent with the original approval; Adverse reactions, drug interactions and other contents, the instructions provided by the enterprise can not be less than those listed in the sample draft. For empty or incomplete items in the sample manual, enterprises should be required to fill in according to the actual situation, such as product name and specifications.
Drug name
Generic name: acetylcysteine capsule
Former name:
Commodity name:
English Name: Acetylcysteine Capsule
Hanyu pinyin: Yixian semi-dry acid capsule
The main component is acetylcysteine. Its chemical name is N acetyl L cysteine.
Structural formula:
Molecular formula: C5H9NO3S
Molecular weight: 163.20
Character; Role; letter
This product is a hard capsule with white particles.
Pharmacology and toxicology
This product is a mucolytic agent. The sulfhydryl group (SH) contained in its molecule can break the disulfide bond (SS) in the polypeptide chain of glycoprotein in sputum, thus reducing the viscosity of sputum and promoting the discharge of sputum.
pharmacokinetics
This product is absorbed quickly after oral administration, reaching the highest blood concentration in about 30 minutes. It is distributed rapidly and widely, and metabolized rapidly in intestinal wall and liver. About 70% of drugs are excreted in the form of sulfate.
indicate
Used for respiratory diseases with excessive phlegm and thick mucus: acute bronchitis, acute attack of chronic bronchitis and bronchiectasis.
dosage
Oral. Adults, 0.2g each time, 2 ~ 3 times a day.
counteraction
Occasionally nausea and vomiting occur, and allergic reactions such as rash and bronchospasm rarely occur.
taboo
It is forbidden for those who are allergic to this product. Use with caution or disable in patients with bronchial asthma.
Matters needing attention
Patients with bronchial asthma should be closely monitored during the use of this product, and if there is bronchospasm, they should stop taking the drug immediately.
Medication for pregnant and lactating women
Pregnant women should follow the doctor's advice.
Children's medication
Follow the doctor's advice.
Medication for elderly patients
drug interaction
1. Avoid taking powerful antitussive drugs together.
2. Not suitable for some metals, such as iron, copper and rubber.
excessive
standard
0.2g
store
Sealed and stored in a cool and dry place.
parcel
Aluminum-plastic blister packaging.
term of validity
Registration authentication number
Production enterprise
Enterprise name:
Address:
Postal code:
Telephone number:
Fax number:
Website: